Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haixia Cheng

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
ACS Applied Bio Materials|January 22, 2025
Antifouling and Bactericidal Zwitterionic Polymer Coatings with Synergistic Inhibitory and Killing PropertiesFei Ma, Xinde Tang, Yanan Chao, et al.
Journal of Neuro-Oncology|November 4, 2022
Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression riskLingyang Hua, Leihao Ren, Qian Wu, et al.
BMC Genomics|May 3, 2012
Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinomaElana J Fertig, Qing Ren, Haixia Cheng, et al.
European Radiology|October 18, 2023
Predicting meningioma grades and pathologic marker expression via deep learningJiawei Chen, Yanping Xue, Leihao Ren, et al.
Frontiers in Oncology|May 14, 2023
Multi-b-value diffusion stretched-exponential model parameters correlate with MIB-1 and CD34 expression in Glioma patients, an intraoperative MR-navigated, biopsy-based histopathologic studyJunlong Wang, Hua Zhang, Xuefei Dang, et al.
Clinical Medicine Insights. Oncology|July 15, 2025
Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical TrialXiaojie Ding, Di Chen, Zhenyu Zhang, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 11, 2024
A Convolutional Neural Network Model for Distinguishing Hemangioblastomas From Other Cerebellar-and-Brainstem Tumors Using Contrast-Enhanced MRIYaru Sheng, Botao Zhao, Haixia Cheng, et al.
Molecules and Cells|June 9, 2022
LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 PathwayYaodong Ding, Yu Ge, Daijun Wang, et al.
Experimental Hematology & Oncology|June 13, 2025
Comprehensive molecular characterization of adult H3K27M mutated thalamic glioma long-term survivorsHao Xu, Xiaomu Hu, Biyun Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 2, 2024
Presurgical Medical Treatment in Prolactinomas: Surgical Implications and Pathological Characteristics From 290 CasesZhengyuan Chen, Xuefei Shou, Lijin Ji, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
ACS Applied Bio Materials|January 22, 2025
Antifouling and Bactericidal Zwitterionic Polymer Coatings with Synergistic Inhibitory and Killing PropertiesFei Ma, Xinde Tang, Yanan Chao, et al.
Journal of Neuro-Oncology|November 4, 2022
Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression riskLingyang Hua, Leihao Ren, Qian Wu, et al.
BMC Genomics|May 3, 2012
Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinomaElana J Fertig, Qing Ren, Haixia Cheng, et al.
European Radiology|October 18, 2023
Predicting meningioma grades and pathologic marker expression via deep learningJiawei Chen, Yanping Xue, Leihao Ren, et al.
Frontiers in Oncology|May 14, 2023
Multi-b-value diffusion stretched-exponential model parameters correlate with MIB-1 and CD34 expression in Glioma patients, an intraoperative MR-navigated, biopsy-based histopathologic studyJunlong Wang, Hua Zhang, Xuefei Dang, et al.
Clinical Medicine Insights. Oncology|July 15, 2025
Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical TrialXiaojie Ding, Di Chen, Zhenyu Zhang, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 11, 2024
A Convolutional Neural Network Model for Distinguishing Hemangioblastomas From Other Cerebellar-and-Brainstem Tumors Using Contrast-Enhanced MRIYaru Sheng, Botao Zhao, Haixia Cheng, et al.
Molecules and Cells|June 9, 2022
LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 PathwayYaodong Ding, Yu Ge, Daijun Wang, et al.
Experimental Hematology & Oncology|June 13, 2025
Comprehensive molecular characterization of adult H3K27M mutated thalamic glioma long-term survivorsHao Xu, Xiaomu Hu, Biyun Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|January 2, 2024
Presurgical Medical Treatment in Prolactinomas: Surgical Implications and Pathological Characteristics From 290 CasesZhengyuan Chen, Xuefei Shou, Lijin Ji, et al.
Pageof 8